Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

The impact of the COVID-19 pandemic and the changing landscape of CF on the cASPerCF trial: a real-world experience

Chesshyre ELD. et al, (2024), Trials, 25

Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)-Targeted Therapeutics for Cystic Fibrosis

Veselu D-F. et al, (2024), Ion Channels as Targets in Drug Discovery, 239 - 284

Development of an inhibitor of the mutagenic SOS response that suppresses the evolution of quinolone antibiotic resistance

Bradbury JD. et al, (2024), Chemical Science

A multinational report on SARS-COV-2 infection outcomes in people with CF and Aspergillus infection or ABPA.

Bradbury JD. et al, (2023), J Cyst Fibros

Include forthcoming?